Rapid evaluation of the safety of COVID-19 vaccines: how well have we done?

Elizabeth Miller

doi:10.1016/j.cmi.2021.12.018

Rapid evaluation of the safety of COVID-19 vaccines: how well have we done?

Elizabeth Miller^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

9 Citations (Scopus)

Original language	English
Pages (from-to)	477-478
Number of pages	2
Journal	Clinical Microbiology and Infection
Volume	28
Issue number	4
DOIs	https://doi.org/10.1016/j.cmi.2021.12.018
Publication status	Published - Apr 2022
Externally published	Yes

Bibliographical note

Funding Information:
Elizabeth Miller receives support from the National Institute for Health Research , Health Protection Research Unit in Immunisation , at the London School of Hygiene and Tropical Medicine in partnership with Public Health England (Grant Reference NIHR200929). The author declares no competing interests.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Bells palsy and COVID-19 vaccine
COVID-19 vaccine safety
GBS and COVID-19 vaccine
Myocarditis and COVID-19 vaccine
Thrombosis and COVID-19 vaccine

Access to Document

10.1016/j.cmi.2021.12.018

Cite this

@article{9bbde6f4d3204c92a17eba7ded82e91a,

title = "Rapid evaluation of the safety of COVID-19 vaccines: how well have we done?",

keywords = "Bells palsy and COVID-19 vaccine, COVID-19 vaccine safety, GBS and COVID-19 vaccine, Myocarditis and COVID-19 vaccine, Thrombosis and COVID-19 vaccine",

author = "Elizabeth Miller",

note = "Funding Information: Elizabeth Miller receives support from the National Institute for Health Research , Health Protection Research Unit in Immunisation , at the London School of Hygiene and Tropical Medicine in partnership with Public Health England (Grant Reference NIHR200929). The author declares no competing interests.",

year = "2022",

month = apr,

doi = "10.1016/j.cmi.2021.12.018",

language = "English",

volume = "28",

pages = "477--478",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier B.V.",

number = "4",

}

TY - JOUR

T1 - Rapid evaluation of the safety of COVID-19 vaccines

T2 - how well have we done?

AU - Miller, Elizabeth

N1 - Funding Information: Elizabeth Miller receives support from the National Institute for Health Research , Health Protection Research Unit in Immunisation , at the London School of Hygiene and Tropical Medicine in partnership with Public Health England (Grant Reference NIHR200929). The author declares no competing interests.

PY - 2022/4

Y1 - 2022/4

KW - Bells palsy and COVID-19 vaccine

KW - COVID-19 vaccine safety

KW - GBS and COVID-19 vaccine

KW - Myocarditis and COVID-19 vaccine

KW - Thrombosis and COVID-19 vaccine

UR - https://www.scopus.com/pages/publications/85123095119

U2 - 10.1016/j.cmi.2021.12.018

DO - 10.1016/j.cmi.2021.12.018

M3 - Comment/debate

AN - SCOPUS:85123095119

SN - 1198-743X

VL - 28

SP - 477

EP - 478

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

IS - 4

ER -

Rapid evaluation of the safety of COVID-19 vaccines: how well have we done?

Bibliographical note

UN SDGs

Keywords

Access to Document

Other files and links

Cite this